SAVA Q4 2022 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$116M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$18M

Operating Income

-$21M

Net Income

-$19M

EPS (Diluted)

$-0.43

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$616,000

Balance Sheet

Total Assets

$235M

Total Liabilities

$7M

Stockholders' Equity

$228M

Cash & Equivalents

$201M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$18M	-$10M	-70.7%
Operating Income	-$21M	-$14M	-45.0%
Net Income	-$19M	-$14M	-35.0%